C16 Biosciences
Bioprocessing · Industrial Biotechnology
$28.9Mtotal raised · 3 rounds on record
$5Mlatest round · Venture round · Feb 2023 · 3 yr ago
7backers · Plug and Play, Y Combinator
23stories in the press
Overview
0 The science behind better ingredients To unlock the potential of next-generation ingredients, C16 has developed a proprietary biomanufacturing platform to produce high value lipid ingredients that deliver on specific functional needs for manufacturers of beauty, personal and home care, and food applications.
Funding and backers
Total raised
$28.9M
3 rounds on record
Latest round
$5M
Venture round · Feb 2023 · 3 yr ago
Backers
7
Plug and Play, Y Combinator
The money's age
Long since its last round
44 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 21, 2023
Raised a round Venture round $5M · SEC Form D
Mar 11, 2020
Board appointment Peter Turner, Director · SEC Form D
Feb 14, 2020
Raised a round Venture round $20M · SEC Form D
Aug 16, 2018
Raised a round Convertible Note $4M · SEC Form D
Jun 2018
Went through Y Combinator
2017
Founded
Tractionpublic signals, read monthly
Web presence
top 3%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2023 | $5M | — | SEC Form D |
| Venture round | Feb 2020 | $20M | — | SEC Form D |
| Convertible Note | Aug 2018 | $4M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | C16 Biosciences, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Shara TickuExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Plug and Play 
Y Combinator Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Hyper-functional ingredients developed through pioneering forms of purification and biomanufacturing.
Lyric Bio, Inc. is building next generation biomanufacturing for human donor sourced therapeutics.
Cauldron is pioneering next-generation bioprocess innovation to accelerate industrial-scale, commercially viable biomanufacturing.
Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at…
We convert nature's best molecular factories into the biomanufacturing platform of the future.
Biosphere is replacing the 1950's steam bioreactor with amodern, UV-enabled design that reduces the capital intensity of biomanufacturing.
Visa sponsorship
0
H-1B filings in 12 months
1
Green card filings
$118k
Median offered salary
In the register as C16 Biosciences, Inc., New York, NY
Other sponsors in the same field
Celltrio 
Daiichi Sankyo 
Dechert 
KBI Biopharma
Alert me
US Department of Labor · latest filing Sep 5, 2025 · Visa details by country
People
Shara Ticku
Executive Officer, Director
Harold McNamara
Director
David Heller
Director
Andrew Shumaker
Director
Peter Turner
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
UpHonest CapitalVia a fund
Elemental ImpactVia a fund
Dorm Room FundVia a fund
196 portfolio companies: Perennial Climate Inc., Pashionfootwear, 2026 Habitual Money Inc. and 193 more
DCVCVia a fund
Soma CapitalVia a fund
876 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Palmless by C16 Biosciences Launches First Food Ingredient and Expands Beauty Portfolio
NEW YORK, July 30, 2026--C16 Biosciences, the makers of Palmless, Launches First Food Ingredient and Expands Beauty Portfolio
Read more
Report
Report
Palmless by C16 Biosciences Unveils Groundbreaking Efficacy Data for Torula Oil
NEW YORK, July 16, 2026--C16 Biosciences, the makers of Palmless, has released a comprehensive new data package detailing the efficacy of Torula Oil, revealing performance capabilities that redefine what a single cosmetic ingredient can do.
Read more
Report
The Estée Lauder Companies and NYKAA Announce Winners of the Second Edition of BEAUTY&YOU India
BEAUTY&YOU is an awards program that aims to discover, spotlight, and propel the next generation of Indian-focused beauty founders, innovators, and creatives. NEW YORK --(BUSINESS WIRE)-- The Estée Lauder Companies (ELC) and NYKAA, one of India's leading
Read more
Report
Report
C16 Biosciences: $3.5 Million Grant Received From Gates Foundation
C16 Biosciences - the makers of Palmless, a platform for sustainable palm oil alternatives - announced it is ramping up its capabilities in the food category, driven by a $3.5 million grant from the Bill & Melinda Gates Foundation and a $1 million investm
Read more
Report
The 57 Most Innovative Beauty Products of 2023
The future of beauty starts here, with our picks of the latest breakthrough products, formulas, and solutions for the 2023 Harper
Read more
Report
Could this sustainable palm oil alternative change skincare?
Palm oil is one of the most destructive ingredients on the planet, but also one of the most commonly used in cosmetics - Pangaia and Haeckels think they have found a solution
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ